SCHEMBL27646

SCHEMBL27646

C1CC2CCC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18760074 1.00
SCHEMBL134032 1.00
Methane SCHEMBL7940021 0.93
Methane SCHEMBL6180360 0.87
SCHEMBL18897676 0.82 ALDH1A1 (0.89)
Methyl Alcohol SCHEMBL3851435 0.82
SCHEMBL21841873 0.82 ALDH1A1 (0.89)
SCHEMBL22129611 0.82
Benzene SCHEMBL3778558 0.82 ALDH1A1 (0.42)
SCHEMBL22374 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753936-A1 PYRIDONE DERIVATIVE, COMPOSITION THEREOF AND APPLICATION THEREOF AS ANTI-INFLUENZA DRUG Jiangxi Caishi Pharmaceutical Technology Co., Ltd. (CN) 2020-12-23 EP claimed
EP-3642264-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF Momentive Performance Materials Inc. (US) 2020-04-29 EP claimed
US-10385210-B2 Curable silicone composition and applications and uses thereof MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2019-08-20 US claimed
WO-2019141179-A1 PYRIDONE DERIVATIVE, COMPOSITION THEREOF AND APPLICATION THEREOF AS ANTI-INFLUENZA DRUG 银杏树药业(苏州)有限公司 2019-07-25 WO claimed
US-10287400-B2 Curable silicone composition and applications and uses thereof MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2019-05-14 US claimed
EP-3443027-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF Momentive Performance Materials Inc. (US) 2019-02-20 EP claimed
WO-2018236679-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-12-27 WO claimed
US-20180362764-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2018-12-20 US claimed
US-20170298188-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2017-10-19 US claimed
WO-2017180329-A1 CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2017-10-19 WO claimed
US-20260138961-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION PRETZEL THERAPEUTICS, INC. (US) 2026-05-21 US disclosed
EP-4743453-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION Pretzel Therapeutics, Inc. (US) 2026-05-20 EP disclosed
EP-4743081-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION Pretzel Therapeutics, Inc. (US) 2026-05-20 EP disclosed
CN-122055172-A Chimeric radiopharmaceuticals targeting the proton-sensitive receptor GPR4 安菲利克斯股份公司 2026-05-15 CN disclosed
EP-3891149-B1 RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2026-01-28 EP disclosed
EP-0990634-A1 ACYLATING AGENTS, ACYLATION METHOD WITH THE USE OF THE SAME AND ADAMANTANE DERIVATIVES Daicel Chemical Industries, Ltd. (JP) 2000-04-05 EP disclosed
US-5003074-A N-fluorinated sulfonamides CIBA-GEIGY CORPORATION (US) 1991-03-26 US disclosed
EP-0311086-A1 N-fluorinated sulfon amides, process for their preparation and their use CIBA-GEIGY AG (CH) 1989-04-12 EP disclosed
US-4496742-A Analogs of 5,6-dihydro PGI2 THE UPJOHN COMPANY (US) 1985-01-29 US disclosed
EP-0077209-A1 Nitrogen-containing prostacyclin analogues and compositions containing them THE UPJOHN COMPANY (US) 1983-04-20 EP disclosed